The US health insurance industry resents being on the receiving end of surprise bills and price-gouging, so Blue Cross/Blue Shield are spending $55m to have the nonprofit Civica Rx tool up to make generics of off-patent drugs whose sole manufacturers are shkreliing the prices into the stratosphere.
Civica already supplies drugs to 1,200 hospitals.
…
addicted-2-tea liked this nonnevot liked this
awfullynice-hq reblogged this from merelygifted radioblueheart reblogged this from merelygifted
merelygifted posted this
